Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Relieving Endoplasmic Reticulum Stress May Prevent Some Types of Chronic Disease

By LabMedica International staff writers
Posted on 08 Jul 2015
A team of cell biologists has identified an enzyme that protects cells against endoplasmic reticulum (ER) stress and prevents the apoptosis that characterizes such chronic diseases as Wolfram syndrome, diabetes, heart disease, and Parkinson's disease.

Among its many activities, the endoplasmic reticulum folds and modifies newly formed proteins so they have the correct three-dimensional shape to function properly. More...
The ER also helps transport proteins, fats, and other materials to specific sites within the cell or to the cell surface. When placed under certain types of stress, the ER can leak molecules into other parts of the cell, which can trigger the apoptotic pathway that leads to cell death and eventually to organ dysfunction.

Investigators at Washington University School of Medicine (St. Louis, MO, USA) reported in the June 23, 2015, on line edition of the journal Science Signaling that they had identified a mechanism by which the enzyme IRE1 conferred protection against ER stress-mediated cell death. In humans, IRE1 is called "ER to nucleus signaling 1 protein." This protein possesses intrinsic kinase activity and an endoribonuclease activity, and it is important in altering gene expression as a response to ER-based stress signals.

The investigators found that IRE1 signaling prevented ER membrane permeabilization mediated by the proteins Bax and Bak and cell death in cells experiencing ER stress. In response to ER stress, cells deficient in IRE1 were found to be susceptible to leakage of ER contents, which was associated with the accumulation of calcium in mitochondria, oxidative stress in the cytosol, and ultimately cell death.

Senior author Dr. Fumihiko Urano, professor of medicine at Washington University School of Medicine, said, "We believe the enzyme we identified may provide us with a target to protect many types of cells from a death cascade that leads to those different, seemingly unrelated disorders. It is clear from our experiments that this enzyme can keep the membrane in the cell from becoming permeable and leaking. We think it may be possible to prevent Wolfram syndrome and other diseases related to this type of cellular stress by targeting the enzyme to make the membrane stronger."

Related Links:

Washington University School of Medicine



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.